Madeleine North
August 13, 2025
This video is part of: Centre for Health and Healthcare
It has proved effective against a long list of drug-resistant bacteria. That together kills more than 1 million people each year. Most antibiotics are derived from fungi and soil bacteria.
Harvard scientists' new synthetic antibiotic, cresomycin, combats drug-resistant bacteria (killing over 1 million yearly) is a major leap forward as existing natural antibiotics are losing effectiveness due to resistance.
Cresomycin's advantage lies in its synthetic nature. Unlike traditional antibiotics that target ribosomes (essential for bacterial growth) and can be deactivated by bacterial defenses, cresomycin is specifically designed to overcome these defenses.
Antimicrobial resistance (AMR) is a critical public health threat. If left unchecked, AMR-related deaths could reach 10 million annually by 2050.
Researchers are exploring new avenues in the fight against superbugs. Scientists at MIT have utilized artificial intelligence (AI) to identify the first new antibiotic candidates in decades
The World Economic Forum's Global Future Council on the Future of Tackling Antimicrobial Resistance is an initiative dedicated to finding innovative approaches to combat AMR.
Madeleine North
August 13, 2025
Charlotte Edmond
August 11, 2025
Adriana Banozic-Tang and Heng Wang
August 5, 2025
Tom Crowfoot
July 30, 2025
Pranidhi Sawhney and Adam Skali
July 29, 2025